Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × copanlisib × Clear all

Phase

Status

Terminated 5 Active not recruiting 5 Completed 4 Withdrawn 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cisplatin 244 Carboplatin 172 Oxaliplatin 163 Capecitabine 159 Docetaxel 156 apatinib 152 Paclitaxel 145 Gemcitabine 138 Bevacizumab 134 Radiotherapy 132 camrelizumab 129 Fluorouracil 127 Cyclophosphamide 116 Irinotecan 109 Drug Therapy 93 Etoposide 92 sintilimab 89 S 1 (combination) 77 Leucovorin 73 anlotinib 71 Doxorubicin 70 pembrolizumab 69 toripalimab 66 tislelizumab 66 Pemetrexed 66 Dexamethasone 62 Rituximab 61 Neoadjuvant Therapy 59 Cetuximab 58 Trastuzumab 57

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04263584 2024-01-05

COPA-R-CHOP

University Hospital Muenster

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡